Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial - Concepedia

Concepedia

Publication | Closed Access

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

298

Citations

13

References

2018

Year

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald, Gary T. Ferguson, Peter Barker, Stephanie Sproule, Richard F. Olsson, Ubaldo J. Martin, Mitchell Goldman, Anahí Yañez,

The Lancet Respiratory Medicine

AsthmaRheumatologyExtension TrialAllergyAllergy MedicineClinical TrialsPulmonary PharmacologyPharmacotherapyPharmacologic InterventionLong-term SafetyMedicineBora Phase 3Clinical Allergy

References

	Year	Citations

Page 1

Page 1